Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurocognitive Function Changes With Envarsus XR Conversion vs Prograf Maintenance in Older Kidney Transplant Recipients
NCT06751992Phase 4Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2026
- Primary completion
- May 2027
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by Massachusetts General Hospital. Started Mar 2026; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT06751992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06751992.